 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 01, 2022 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD, a company focused on the development and commercialization of innovative therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the H.C. Wainwright 24th Annual Global Investment Conference on Tuesday, September 13, 2022 at 12:00 PM ET at the Lotte New York Palace Hotel. 